International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019

Viral Infections, Non-HIV

Core Outcomes Set for Trials in People With Coronavirus Disease 2019

Crit Care Med.

Tong A, Elliott JH, Azevedo LC, Baumgart A, Bersten A, Cervantes L, Chew DP, Cho Y, Cooper T, Crowe S, Douglas IS, Evangelidis N, Flemyng E, Hannan E, Horby P, Howell M, Lee J, Liu E, Lorca E, Lynch D, Marshall JC, Matus Gonzalez A, McKenzie A, Manera KE, McLeod C, Mehta S, Mer M, Conway Morris A, Nseir S, Povoa P, Reid M, Sakr Y, Shen N, Smyth AR, Snelling T, Strippoli GF, Teixeira-Pinto A, Torres A, Turner T, Viecelli AK, Webb S, Williamson PR, Woc-Colburn L, Zhang J, Craig JC, COVID-19-Core Outcomes Set (COS) Workshop Investigators.

doi: 10.1097/CCM.0000000000004585.

Viral Infections, Non-HIV

Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

Crit Care Med

Santoro F, Núñez-Gil IJ, Viana-Llamas MC, Maroun Eid C, Romero R, Fernández Rozas I, Parisi A, Becerra-Muñoz VM, García Aguado M, Huang J, Maltese L, Cerrato E, Alfonso-Rodriguez E, Castro Mejía AF, Marin F, Raposeiras Roubin S, Pepe M, Moreno Munguia VH, Feltes G, Navas JV, Cortese B, Buzón L, Liebetrau C, Ramos-Martinez MR, Fernandez-Ortiz A, Estrada V, Brunetti ND

doi: 10.1097/CCM.0000000000005010

Viral Infections, Non-HIV

Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials

Crit Care Med

Buchman TG, Draghia-Akli R, Adam SJ, Aggarwal NR, Fessel JP, Higgs ES, Menetski JP, Read SW, Hughes EA, ACTIV Therapeutics Clinical Working Group.

doi: 10.1097/CCM.0000000000005295

HIV / AIDSViral Infections, Non-HIV

Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review

HIV Med.

Cooper TJ, Woodward BL, Alom S, Harky A

doi: 10.1111/hiv.12911.

Viral Infections, Non-HIV

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

BMJ

Veiga VC, Prats JAGG, Farias DLC, Rosa RG, Dourado LK, Zampieri FG, Machado FR, Lopes RD, Berwanger O, Azevedo LCP, Avezum Á, Lisboa TC, Rojas SSO, Coelho JC, Leite RT, Carvalho JC, Andrade LEC, Sandes AF, Pintão MCT, Castro CG Jr, Santos SV, de Almeida TML, Costa AN, Gebara OCE, de Freitas FGR, Pacheco ES, Machado DJB, Martin J, Conceição FG, Siqueira SRR, Damiani LP, Ishihara LM, Schneider D, de Souza D, Cavalcanti AB, Scheinberg P, Coalition covid-19 Brazil VI Investigators.

doi: 10.1136/bmj.n84

Viral Infections, Non-HIV

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial

JAMA Netw Open.

Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C, GRECCO-19 investigators.

doi: 10.1001/jamanetworkopen.2020.13136.

Viral Infections, Non-HIV

Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease

Eur Heart J

Diller GP, Gatzoulis MA, Broberg CS, Aboulhosn J, Brida M, Schwerzmann M, Chessa M, Kovacs AH, Roos-Hesselink J

doi: 10.1093/eurheartj/ehaa960

Viral Infections, Non-HIV

Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome

Am J Transplant.

Xia T, Wang Y

doi: 10.1111/ajt.15992.

Viral Infections, Non-HIV

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Lancet Infect Dis.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunubá Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM

doi: 10.1016/S1473-3099(20)30243-7.

Related content

Core Outcomes Set for Trials in People With Coronavirus Disease 2019

Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials

Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial

Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease

Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome

Estimates of the severity of coronavirus disease 2019: a model-based analysis